PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 137 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2014. The put-call ratio across all filers is 1.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $39,501,000 | -5.1% | 167,300 | -24.0% | 6.10% | -4.9% |
| Q4 2014 | $41,639,000 | -65.6% | 220,000 | -56.7% | 6.42% | -74.2% |
| Q3 2014 | $121,074,000 | +784.1% | 507,500 | +144.6% | 24.90% | +586.2% |
| Q2 2014 | $13,695,000 | -36.6% | 207,500 | 0.0% | 3.63% | -27.0% |
| Q1 2014 | $21,609,000 | +4.4% | 207,500 | +3.8% | 4.97% | -17.3% |
| Q4 2013 | $20,706,000 | – | 200,000 | – | 6.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |